
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Partial anomalous pulmonary venous connection other imaging findings
Introduction
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[1]
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[1]
Recommendations for Anomalous Pulmonary Venous Connections
| Class I |
| 1.”CMR or CTA is recommended for evaluation of partial anomalous pulmonary venous connection. (Level of Evidence: B-NR)” |
| Class IIa |
| 1.”Cardiac catheterization can be useful in adults with partial anomalous pulmonary venous connection to further define hemodynamics (Level of Evidence: B-NR)” |
Volume overload of the right heart caused by an abnormal link between a pulmonary vein and a systemic vein will have physiological effects resembling those of an ASD. However, anomalous pulmonary venous connection differs from related ASD in that there is no chance for right-to-left shunting, and the severity of the left-to-right shunt is not increased by the onset of acquired left heart disease. The right upper pulmonary vein’s connection to the superior vena cava, which may be accompanied by a sinus venosus defect, is the most frequent aberrant pulmonary venous connection.
References
References
- ↑ Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM; et al. (2019). “2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines”. J Am Coll Cardiol. 73 (12): 1494–1563. doi:10.1016/j.jacc.2018.08.1028. PMID 30121240.
